These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37304832)

  • 1. Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson's Disease in Xinjiang.
    Wei R; Zhang Y; Li P; Xu Z; Zhang L; He Y; Wu Q; Shi Y; Yuan Y; Aisha A
    Parkinsons Dis; 2023; 2023():8867546. PubMed ID: 37304832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.
    Li T; Shi J; Qin B; Fan D; Liu N; Ni J; Zhang T; Zhou H; Xu X; Wei M; Zhang X; Wang X; Liu J; Wang Y; Tian J
    Neurol Sci; 2020 Mar; 41(3):661-667. PubMed ID: 31754876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features in Parkinson's Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study.
    Zhu S; Wang Y; Jiang Y; Gu R; Zhong M; Jiang X; Shen B; Zhu J; Yan J; Pan Y; Zhang L
    Neuropsychiatr Dis Treat; 2022; 18():1593-1601. PubMed ID: 35942277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram based on neuron-specific enolase and substantia nigra hyperechogenicity for identifying cognitive impairment in Parkinson's disease.
    Hou C; Yang F; Li S; Ma HY; Li FX; Zhang W; He W
    Quant Imaging Med Surg; 2024 May; 14(5):3581-3592. PubMed ID: 38720848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson's Disease.
    Zhang S; Tao K; Wang J; Duan Y; Wang B; Liu X
    Front Cell Neurosci; 2020; 14():216. PubMed ID: 32848616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
    J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.
    Hoeppner J; Prudente-Morrissey L; Herpertz SC; Benecke R; Walter U
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):92-7. PubMed ID: 18806917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease.
    Zhu Y; Wang B; Tao K; Yang H; Wang Y; Zhou T; Yang Y; Yuan L; Liu X; Duan Y
    Parkinsonism Relat Disord; 2017 Mar; 36():76-82. PubMed ID: 28108264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia nigra hyperechogenicity in Polish patients with Parkinson's disease.
    Ambrosius W; Michalak S; Owecki M; Łukasik M; Florczak-Wyspiańska J; Kozubski W
    Folia Morphol (Warsz); 2014 Aug; 73(3):267-71. PubMed ID: 25706660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of substantia nigra hyperechogenicity to risk of Lewy body disease in idiopathic REM sleep behavior disorder patients: a longitudinal study.
    Miyamoto M; Miyamoto T
    Sleep Med; 2020 Apr; 68():31-34. PubMed ID: 32018190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the substantia nigra echogenicity and
    Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
    Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
    Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
    J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
    Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
    Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
    Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
    Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Performance of Transcranial Sonography for Evaluating Substantia Nigra Hyper-echogenicity in Patients with Parkinson's Disease.
    Xu R; Chen G; Mao Z; Gao H; Deng Y; Tao A
    Ultrasound Med Biol; 2020 May; 46(5):1208-1215. PubMed ID: 32102740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.
    Alonso-Canovas A; Lopez-Sendon Moreno JL; Buisan J; Sainz de la Maza S; Costa-Frossard L; Garcia-Ribas G; de Felipe-Mimbrera A; Matute-Lozano MC; Zarza Sanz B; Toledano Delgado R; Corral I; Masjuan J; Martinez-Castrillo JC
    J Neurol; 2018 Oct; 265(10):2363-2369. PubMed ID: 30116942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.